Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Journal of Medicinal Chemistry
|
October 30, 2025
Discovery of Highly Potent and Orally Available CCNK Molecular Glue Degraders as Broad-Spectrum Antitumor Agents
Yuxia Liu, Zhongcheng Yang, Zibin Liao, et al.
Reproductive Biology
|
October 12, 2025
Testis-specific gene C3ORF22/BC048671 is dispensable for spermiogenesis and male fertility
Shiyue Du, Yongfu Liu, Le Wang, et al.
European Journal of Medicinal Chemistry
|
April 4, 2024
Design, synthesis, and biological evaluation of first-in-class FABP1 inhibitors for the treatment of NASH
Ya Chen, Mingyang Yu, Lianru Chen, et al.
The FEBS Journal
|
September 7, 2018
phlda3 overexpression impairs specification of hemangioblasts and vascular development
Xiaojing Wang, Jia Li, Zhongcheng Yang, et al.
Biochemical Pharmacology
|
August 11, 2023
Discovery of novel carboxylesterase 2 inhibitors for the treatment of delayed diarrhea and ulcerative colitis
Zhijun Cao, Yuxia Liu, Siliang Chen, et al.
Bioorganic Chemistry
|
June 10, 2023
Design, synthesis, and biological evaluation studies of novel carboxylesterase 2 inhibitors for the treatment of irinotecan-induced delayed diarrhea
Zhongcheng Yang, Zhijun Cao, Wenxin Wang, et al.
European Journal of Medicinal Chemistry
|
November 7, 2022
Discovery of a structurally novel, potent, and once-weekly free fatty acid receptor 1 agonist for the treatment of diabetes
Bin Wang, Zongyu Cai, Huixin Yao, et al.
Viruses
|
March 1, 2017
Evaluation of Rice Resistance to Southern Rice Black-Streaked Dwarf Virus and Rice Ragged Stunt Virus through Combined Field Tests, Quantitative Real-Time PCR, and Proteome Analysis
Zhenchao Wang, Lu Yu, Linhong Jin, et al.
Journal of Medicinal Chemistry
|
January 24, 2025
Discovery of First-in-Class FXR and HSD17B13 Dual Modulator for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease
Shixuan Jiao, Qiang Ren, Lianru Chen, et al.
Journal of Medicinal Chemistry
|
April 20, 2023
Discovery of the First-in-Class Intestinal Restricted FXR and FABP1 Dual Modulator ZLY28 for the Treatment of Nonalcoholic Fatty Liver Disease
Qiang Ren, Ya Chen, Zongtao Zhou, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Journal of Medicinal Chemistry
|
October 30, 2025
Discovery of Highly Potent and Orally Available CCNK Molecular Glue Degraders as Broad-Spectrum Antitumor Agents
Yuxia Liu, Zhongcheng Yang, Zibin Liao, et al.
Reproductive Biology
|
October 12, 2025
Testis-specific gene C3ORF22/BC048671 is dispensable for spermiogenesis and male fertility
Shiyue Du, Yongfu Liu, Le Wang, et al.
European Journal of Medicinal Chemistry
|
April 4, 2024
Design, synthesis, and biological evaluation of first-in-class FABP1 inhibitors for the treatment of NASH
Ya Chen, Mingyang Yu, Lianru Chen, et al.
The FEBS Journal
|
September 7, 2018
phlda3 overexpression impairs specification of hemangioblasts and vascular development
Xiaojing Wang, Jia Li, Zhongcheng Yang, et al.
Biochemical Pharmacology
|
August 11, 2023
Discovery of novel carboxylesterase 2 inhibitors for the treatment of delayed diarrhea and ulcerative colitis
Zhijun Cao, Yuxia Liu, Siliang Chen, et al.
Bioorganic Chemistry
|
June 10, 2023
Design, synthesis, and biological evaluation studies of novel carboxylesterase 2 inhibitors for the treatment of irinotecan-induced delayed diarrhea
Zhongcheng Yang, Zhijun Cao, Wenxin Wang, et al.
European Journal of Medicinal Chemistry
|
November 7, 2022
Discovery of a structurally novel, potent, and once-weekly free fatty acid receptor 1 agonist for the treatment of diabetes
Bin Wang, Zongyu Cai, Huixin Yao, et al.
Viruses
|
March 1, 2017
Evaluation of Rice Resistance to Southern Rice Black-Streaked Dwarf Virus and Rice Ragged Stunt Virus through Combined Field Tests, Quantitative Real-Time PCR, and Proteome Analysis
Zhenchao Wang, Lu Yu, Linhong Jin, et al.
Journal of Medicinal Chemistry
|
January 24, 2025
Discovery of First-in-Class FXR and HSD17B13 Dual Modulator for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease
Shixuan Jiao, Qiang Ren, Lianru Chen, et al.
Journal of Medicinal Chemistry
|
April 20, 2023
Discovery of the First-in-Class Intestinal Restricted FXR and FABP1 Dual Modulator ZLY28 for the Treatment of Nonalcoholic Fatty Liver Disease
Qiang Ren, Ya Chen, Zongtao Zhou, et al.
Page
of 4